Granado Daniel, Müller Daria, Krausel Vanessa, Kruzel-Davila Etty, Schuberth Christian, Eschborn Melanie, Wedlich-Söldner Roland, Skorecki Karl, Pavenstädt Hermann, Michgehl Ulf, Weide Thomas
Department of Internal Medicine D and.
Department of Nephrology, Rambam Health Care Campus, Haifa, Israel.
J Am Soc Nephrol. 2017 Nov;28(11):3227-3238. doi: 10.1681/ASN.2016111220. Epub 2017 Jul 10.
Population genetic approaches have uncovered a strong association between kidney diseases and two sequence variants of the gene, called risk variant G1 and variant G2, compared with the nonrisk G0 allele. However, the mechanism whereby these variants lead to disease manifestation and, in particular, whether this involves an intracellular or extracellular pool of APOL1 remains unclear. Herein, we show a predominantly intracellular localization of APOL1 G0 and the renal risk variants, which localized to membranes of the endoplasmic reticulum in podocyte cell lines. This localization did not depend on the N-terminal signal peptide that mediates APOL1 secretion into the circulation. Additionally, a fraction of these proteins localized to structures surrounding mitochondria. overexpression of G1 or G2 lacking the signal peptide inhibited cell viability, triggered phosphorylation of stress-induced kinases, increased the phosphorylation of AMP-activated protein kinase, reduced intracellular potassium levels, and reduced mitochondrial respiration rates. These findings indicate that functions at intracellular membranes, specifically those of the endoplasmic reticulum and mitochondria, are crucial factors in APOL1 renal risk variant-mediated cell injury.
群体遗传学方法已发现,与无风险的G0等位基因相比,肾脏疾病与该基因的两个序列变异体(称为风险变异体G1和变异体G2)之间存在强烈关联。然而,这些变异体导致疾病表现的机制,尤其是这是否涉及APOL1的细胞内池或细胞外池,仍不清楚。在此,我们展示了APOL1 G0和肾脏风险变异体主要定位于细胞内,它们定位于足细胞系内质网的膜上。这种定位不依赖于介导APOL1分泌到循环中的N端信号肽。此外,这些蛋白质的一部分定位于线粒体周围的结构。缺乏信号肽的G1或G2的过表达抑制细胞活力,触发应激诱导激酶的磷酸化,增加AMP激活的蛋白激酶的磷酸化,降低细胞内钾水平,并降低线粒体呼吸速率。这些发现表明,细胞内膜(特别是内质网和线粒体的膜)上的功能是APOL1肾脏风险变异体介导的细胞损伤的关键因素。